PYRIDOXINE-S TAB 50MG 50 MG — DIN 01980734
PYRIDOXINE HYDROCHLORIDE : 50 MG · NUTRI-WEST PRODUCTS LTD. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is PYRIDOXINE-S TAB 50MG?
PYRIDOXINE-S TAB 50MG 50 MG contains PYRIDOXINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 01980734, held by NUTRI-WEST PRODUCTS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-1997. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Pyridoxine (Vit B6) cost around the world?
Pyridoxine (Vit B6) is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Saudi Arabia publishes a public; United Kingdom publishes a hospital. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 7 | 9 | SAR███.██ |
| United Kingdom | hospital | 1 | 1 | GBP███.██ |
10 pack listings across 8 brand entries and 2 price bases, refreshed 01 Sep 2026. Ranges span every Pyridoxine (Vit B6) pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Pyridoxine (Vit B6) in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
52 holders have a Canadian DIN containing Pyridoxine (Vit B6), across 82 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| MYLAN PHARMACEUTICALS ULC | 1 | 1 | PYRIDOXINE HYDROCHLORIDE INJECTION, USP | Sourceable in Canada |
| GAHLER ENTERPRISES LTD. | 5 | 0 | B-6 500MG CONTINUOUS RELEASED, B6 CAP 100MG, B6 PYRIDOXINE HCL TAB 50MG, B6 TABLETS 100MG, KLB6 TABLETS 17MG | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 4 | 0 | VITAMIN B6 CAPSULES 3.5MG, VITAMIN B6 TAB 250MG, VITAMIN B6 TAB 25MG, VITAMIN B6 TAB 50MG | No marketed DIN |
| GREAT EARTH COMPANIES, INC. | 3 | 0 | VITAMIN B6 100MG, VITAMIN B6 200MG, VITAMIN B6 50MG | No marketed DIN |
| HOLISTA HEALTH (CANADA) INC. | 3 | 0 | PROS-GARD ZINC AND VITAMIN B6 - CAPSULE, PROSGARD, VITAMIN B6 100 MG | No marketed DIN |
| NUTRACEUTICAL CORPORATION | 3 | 0 | P & SP SPECIAL FORMULA, VITAMIN B-6 100MG, VITAMIN B-6 200MG | No marketed DIN |
| QUEST VITAMINS A DIV OF PURITY LIFE HEALTH PRODUCTS | 3 | 0 | VITAMIN B6 CAP 250MG, VITAMIN B6 CAPSULES 100MG, VITAMIN B6 TAB 50MG | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 3 | 0 | PYRIDOXINE HCL TAB 25MG, VITAMIN B6, VITAMIN B6 TAB 100MG | No marketed DIN |
| SWISS HERBAL REMEDIES LTD. | 3 | 0 | HI POTENCY KLB6 TAB 17MG, PYRIDOXINE HCL TAB 25MG, PYRIDOXINE HCL TAB 50MG | No marketed DIN |
| ACTI-FORM LTD. | 2 | 0 | ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 100 TAB, ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 250 TAB | No marketed DIN |
| COUNTRY HEALTH LABORATORIES LTD. | 2 | 0 | SUPER KLB6 TAB 17MG, VITAMIN B6 TAB 100MG | No marketed DIN |
| HEALTH-WISE NUTRITION INC. | 2 | 0 | B6 250 CAPLET 250MG, VITAMIN B6 100MG CAPLET | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Pyridoxine (Vit B6) |
|---|---|
| ATC code | A11HA02 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01980734 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1980734 |
| Brand name | PYRIDOXINE-S TAB 50MG |
| Generic / active ingredient | PYRIDOXINE HYDROCHLORIDE : 50 MG |
| Market authorization holder | NUTRI-WEST PRODUCTS LTD. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A11HA02 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A11HA |
| Current status | CANCELLED POST MARKET |
| Status date | 05-Aug-1997 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Pyridoxine (Vit B6) in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by MYLAN PHARMACEUTICALS ULC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 82 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| PYRIDOXINE HYDROCHLORIDE INJECTION, USP | 100 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | MARKETED | 02245215 |
| ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 100 TAB | 100 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | 00899526 |
| ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 250 TAB | 250 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | 00899534 |
| ACV | 150 MCG | TABLET | ABUNDANCE NATURALLY LTD | CANCELLED POST MARKET | 02243962 |
| B-6 500MG CONTINUOUS RELEASED | 500 MG | TABLET (EXTENDED-RELEASE) | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 00535001 |
| B-6 CAPS 250MG | 250 MG | CAPSULE | TWIN LABORATORIES INC. | CANCELLED POST MARKET | 01984098 |
| B6 100MG PYRIDOXINE HCL | 100 MG | TABLET | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 02243651 |
| B6 25 TAB 25MG | 25 MG | TABLET | LE NATURISTE J.M.B. INC. | CANCELLED POST MARKET | 00850241 |
| B6 250 CAPLET 250MG | 250 MG | TABLET | HEALTH-WISE NUTRITION INC. | CANCELLED POST MARKET | 02005190 |
| B6 400MG CTR TAB | 400 MG | TABLET (EXTENDED-RELEASE) | BIOENERGY INC. | CANCELLED POST MARKET | 00543179 |
2 · Same class — other molecules in ATC A11HA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pyridoxine (Vit B6) | ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 100 TAB · ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 250 TAB · ACV · B-6 500MG CONTINUOUS RELEASED · +66 more | 82 | 1 | Yes |
| Tocopherol (Vit E) | ACTI-COPHEROLS 200 CAP · ACTI-D ALPHACOPHEROL CAP 400UNIT · ACTI-D ALPHACOPHEROL CAP 800UNIT · ACTI-SUCCINATE CAPLET 400UNIT · +185 more | 233 | 0 | Not in Canada |
| Calcium Pantothenate | ACTI PANTOTHENIC ACID 1000 TIMED CAPLET · ACTI-PANTOTHENIC ACID 300 CAPLET 300MG · CALCIUM PANTOTHENATE TAB 250MG · CALPAN TAB 100MG · +27 more | 32 | 0 | Not in Canada |
| Nicotinamide | B3 · NIACINAMIDE · NIACINAMIDE 100 MG TABLETS · NIACINAMIDE 100MG · +14 more | 26 | 0 | Not in Canada |
| Riboflavin (Vit B2) | ACTI-RIBO/RIBO 5-PHOSPH CAPLET · B-2 CAPS 100MG · B2 TAB 100MG · RIBOFLAVIN 5 PHOSPHATE CAP 50MG · +14 more | 18 | 0 | Not in Canada |
| Biotin | ACTI-BIOTIN 300 CAPLET 300MCG · BIOTIN 300 MCG - TABLET · BIOTIN 300 MCG TABLET · BIOTIN 300MCG · +6 more | 12 | 0 | Not in Canada |
| Pyridoxal Phosphate | PYRIDOXAL-5-PHOSPHATE-S TAB 25MG · ROYAL-T VITAMIN AND MINERAL SUPPLEMENT | 2 | 0 | Not in Canada |
| Inositol | INOSITOL 500MG · INOSITOLEX 400MGMS | 2 | 0 | Not in Canada |
| Tocofersolan | AQUASOL E TPGS LIQUID 77IU/ML | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PYRIDOXINE-S TAB 50MG called?
The same molecule, Pyridoxine (Vit B6), is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| NEUROBION tablet | Latin | Saudi Arabia |
| Neurovit | Latin | Saudi Arabia |
| TRIO BE TABLET | Latin | Saudi Arabia |
| VOMINORE TAB | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.